Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Proof-of-Concept Study to Evaluate the Efficacy of NOBO, a Novel Postbiotic, in Controlling Axillary Odor in Healthy Adults
Sponsor: Kingdom
Summary
The goal of this clinical trial is to evaluate the performance of NOBO, a yeast-based fermentation product (postbiotic) designed to control axillary odor, in controlling axillary odor in healthy male and female adults age 18 - 70 with confirmed self-perception of body odor. The main question it aims to answer is: Does NOBO decrease self-perceived odor of the intervention axilla compared to the placebo axilla at any time point? Researchers will compare the intervention axilla to the placebo axilla to see if there is a difference in self-perceived odor and microbiome. Participants will: * be given a NOBO deodorant spray and a placebo deodorant spray (each assigned to one axilla) * self assess body odor * sample axilla with cotton round for 3rd party odor assessment * sample axilla with a swab for skin microbiome analysis via qPCR * self assess skin irritation
Official title: A Randomized, Double-Blind, Placebo-Controlled, Split-Axilla, Proof-of-Concept Study to Evaluate the Efficacy of NOBO, a Novel Postbiotic, in Controlling Axillary Odor in Healthy Adults
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2026-04-16
Completion Date
2026-05-04
Last Updated
2026-04-27
Healthy Volunteers
Yes
Conditions
Interventions
NOBO Aqueous Deodorant
The active ingredient in the NOBO aqueous deodorant is a yeast-based fermentation product (postbiotic) of the Starmerella genus.
Placebo Aqueous Deodorant
The placebo deodorant is composed of ≤ 40% ethanol in water.
Locations (1)
Kingdom
Brooklyn, New York, United States